DATA INTEGRITY ASSURANCE AS KEY FACTOR FOR SURVIVING CORPORATE AUDITS AND REGULATORY INSECTIONS

Size: px
Start display at page:

Download "DATA INTEGRITY ASSURANCE AS KEY FACTOR FOR SURVIVING CORPORATE AUDITS AND REGULATORY INSECTIONS"

Transcription

1 GLOBAL PROVIDER, LOCAL SOLUTIONS IN YOUR LANGUAGE DATA INTEGRITY ASSURANCE AS KEY FACTOR FOR SURVIVING CORPORATE AUDITS AND REGULATORY INSECTIONS Francesco Amorosi PhD Octorber 2017

2 DATA INTEGRITY & CSV: REGULATORY BACKGROUND

3 MEDICINES AND QUALITY OF MEDICINES: ONE POINT OF VIEW ULTIMATE TARGET OF GXP Ensure the Product Quality and Patient Safety within the entire Product Life Cycle from R&D to Distribution 3

4 GLOBALIZATION: NEW CHALLENGES FOR REGULATORS Globalization has fundamentally changed the economic and security landscape : Advances in transportation, telecommunications, infrastructure More outsourcing manufacturing Greater complexity in supply chain Imports coming from countries with less developed regulatory systems Computer Systems and New Technologies are more and more supporting any Actor of the Supply Chain All this demands a major improvement in the way Regulators/Drug Products Manufacturers, Distributors, Suppliers fulfill their mission. 4

5 QUALITY IN 21 ST CENTURY CREATE GLOBAL COALIZATION (to avoid rules interpretation and rely on each others ) PIC/S membership in continuous expansion Inspectional Cooperation Program Jointly announced by FDA & EMA in 2011 (Now in extension and maintenance phase) Formal incorporation of ICH Quality Guidelines into assessor/inspector guidelines (both EU and US Sides) FIGHT COUNTERFEIT Serialization & Aggregation Requirements RELY ON DATA Focus on DATA INTEGRITY (QC and Production) 5

6 DATA INTEGRITY ISSUES PLAGUE OVERSEAS DRUGMAKERS 1/2 Data integrity issues were the most striking findings included in the Office of Manufacturing Quality s 2015 annual report of warning letters. FDA investigators found data manipulation, cover-ups with faked test results, uneven paper trails, destroyed or misplaced records, backdated production reports. The warning letters note problems such as failure of the quality unit to ensure: materials are appropriately tested and the results reported, lack of appropriate controls for batch records, lack of controls for documentation. Moreover, data integrity issues uncovered during an inspection were almost always red flags for larger quality control problems, warning letters indicate 6

7 DATA INTEGRITY ISSUES PLAGUE OVERSEAS DRUGMAKERS 1/2 Each warning letter singled out unauthorized access or changes to data and failure to prevent data omission. The FDA also wants to see detailed management strategies and procedures for getting at root causes of data integrity practices affecting the quality of drug products. Data integrity lapses have become so widespread globally, that even the World Health Organization stepped in last year to issue guidance to bridge the gaps between the principles of good data and record management and actual practices. Most of the letters urged companies to hire a third-party consultant with expertise in data integrity and GMP issues, and drugmakers were urged to review their entire organizational structure and personnel responsibilities. 7

8 DATA INTEGRITY EXPERTS FDA expectations on the role of the Data Integrity Expert Gapless identification (electronic data have been recorded and documented incorrectly). Identification and interview of all employees [ ] and the management which contributed to or caused the GMP deviations. Supporting indications of GMP non-compliant handling of electronic data should be identified. It must be revealed to what extent the top and middle management knew about or was involved in the data manipulation. The data integrity expert should find out whether managers are still able to have an influence on the integrity of GMP relevant data. Internal reviews are to be extended to other sites which are known to be involved in violations of GMP-compliant handling of data 8

9 REQUIREMENTS FOR REGULATED DATA REGULATORY EXPECTATION DATA INTEGRITY The extent to which all data are complete, consistent and accurate throughout the data lifecycle, i.e. from initial data generation and recording through processing (including transformation or migration), use, retention, archiving, retrieval and destruction. Where DATA are generated and used to made GxP quality decisions, ensure it is TRUSTWORTHY and RELIABLE YOUR GxP RECORDS REQUIRED TO BE ALCOA 9

10 WHY DATA INTEGRITY MIGHT BE VIOLATED IN YOUR COMPANY (Anil Sawant- PDA Europe - Data Integrity Workshop - London, 2016) 10

11 POTENTIAL ROOT CAUSE FOR DATA INTEGRITY VIOLATIONS POTENTIAL ROOT CAUSE FOR DATA INTEGRITY VIOLATIONS Business Pressure No Awareness Poor Quality Culture Obsolete / Inadequate Automation Vulnerable Process DATA INTEGRITY VIOLATIONS STATS 80% 20 % Unintentional Intentional 11

12 REACTION OF REGULATED AGENCIES o Increase in number and severity of DI findings by almost every Regulated Agency o Impact to public health o Increased focus OBSERVED STATUS REACTION GxP Data Integrity Definitions and Guidance Guidance on good data and record management practices Data Integrity and compliance with CGMP (draft) Guidance on data Integrity (draft) Records and Data Integrity GUIDE V1 Mar (V2 Jul. 2016) Sept Apr Aug Mar t 12

13 DATA INTEGRITY FOUNDATIONS

14 DATA INTEGRITY GOVERNANCE SYSTEM The Data Governance System will be oriented to establish the Directives to ensure the Integrity of Regulated Data created and maintained by the company for Regulated purposes 14

15 DATA GOVERNANCE SYSTEM FOUNDATION Data Governance Establishment Plan Data Integrity Policy Code of ethics Computer System Policy Training Program Data Integrity Assessment Procedure Audit Trail Review procedure 15

16 DATA GOVERNANCE ESTABLISHMENT PLAN Purpose: Design the Governance System to demonstrate effective data governance practices including the necessity for a combination of appropriate organizational culture and behaviors and an understanding of data criticality, data risk and data lifecycle. This will include: communication of expectations to personnel at all levels within the organization in a manner organizational controls: Procedures, Training Program for Management and staff, Documented authorization for data generation and approval, Routine data verification; Periodic surveillance technical controls: Computerized system control and Automation Both long term and interim measures should be implemented to mitigate risk, and will be monitored for effectiveness. Responsibilities: High management 16

17 DATA INTEGRITY POLICY DI Policy establishes the general approach for GxP data integrity created and maintained by the company. Purpose: set forth the activities to assure the completeness, consistency and accuracy of all data generated in GxP impacting areas and facilities according to the regulatory requirements and to ensure that Regulated data are: attributable, legible, contemporaneous, original and accurate. Responsibilities: High management 17

18 COMPUTER SYSTEM POLICY CS Policy establishes the general approach for implementing, maintaining use of, and retirement of computerized systems in GxP regulated environments Purpose: ensure any CS, IT equipment/service GxP critical is validated or qualificated prior to it use and maintained in a valid state throughout the system lifecycle, together the assurance of data integrity Responsibilities: Management, BPO, TO, QA, IT 18

19 TRAINING PROGRAM Establish a standard approach (methods and responsibilities) for the training Each personnel should be adequately trained in order to fulfil their duties and responsibilities according to their job description guaranteeing to have the knowledge and skills required to perform tasks. Responsibilities: QA 19

20 AUDIT TRAIL REVIEW PROCEDURE The Audit Trail Review is a process to assure that activities related to a system and modifications to the data are executed in a controlled manner, ensuring the integrity of the data managed by the system. Purpose: to define the strategy and methodology to execute the Audit Trail Review assuring data integrity and compliance with the applicable rules. Responsibilities: BO, QA, Supervisor, Application manager, IT, Validation System which manages RER and used to release Finished Products YES Class 1 AUDIT TRAIL REVISION WEEKLY with AQL 1.5 NO - System which manages RER supporting the batch release of Raw Materials or Intermediate Products - System which manages RER supporting Stability Studies - System which manages RER with direct impact on product Quality YES Class 2 AUDIT TRAIL REVISION MONTHLY with AQL 4.0 Revision of the Audit Trail frequency and/ or AQL by QA and Business Owner, increasing or decreasing the conditions based on the identified recurrent deviations and/or anomalies NO Class 3 AUDIT TRAIL REVISION ANNUALLY with AQL

21 COMPUTER VALIDATION LIFE CYCLE PROCEDURE PACKAGE IT Infrastructure Qualification Life Cycle Computer Validation Life Cycle Procedure Supporting Processes Security Management Backup & Restore Archiving Business Continuity System Inventory Management Supplier Assessment Computerized Systems Risk Management Retirement Periodic Review Incident Management Change and Configuration Management 21

22 IT INFRASTRUCTURE QUALIFICATION LIFE CYCLE Demonstrate that infrastructure components (networks, servers, clients, server rooms, software tools) are able to meet the related technical requirements Purpose: defined process for the qualification IT Infrastructure supporting GxP computerized systems, which shall be based on actual risks and regulatory compliance. Responsibilities: IT, QA 22

23 ALCOA ASSESSMENT ELECTRONIC RECORDS CASE STUDY

24 DATA INTEGRITY GOVERNANCE ROADMAP DATA INTEGRITY GOVERNANCE PROCESS INVENTORY PROCESS PRIORITY RANK PROCESS MAPPING & DATA LIFE CYCLE GMP RECORDS INVENTORY LIST OF BUSINESS PROCESSES RISK-BASED PRIORITY ASSOCIATED TO EACH MACROPROCESS PROCESS STEPS ASSOCIATED TO EACH BUSINESS PROCESS & DATA LIFE CYCLE LIST OF GMP RECORDS (BOTH PAPER AND ELECTRONIC) 5 RECORD CLASSIFICATION DETERMINATION OF RECORD CRITICALITY AND TYPE 6 ALCOA GAP ANALYSIS Electronic ALCOA Gap Analysis Paper ALCOA Gap Analysis GAPS AGAINST THE ALCOA REQUIREMENTS 7 INTEGRITY EXPOSURE EVALUATION OF EXPOSURE OF RECORDS TO INTEGRITY VIOLATIONS DETERMINED UPON THE OBSERVED GAPS 8 REMEDIATION PLAN RISK BASED & PRIORITY DRIVEN REMEDIATION PLAN 24

25 REMEDIATION PLAN Risk-based and priority-driven remediation actions Short, Medium and Long remediation phases Finalization Deadline: Q1, 2016 Finalization Deadline: Q2, 2016 Finalization Deadline: Q3, 2016 Computerized Systems Assessment Report & Remediation Plan (present document) SHORT TERM: Remediation Very High Risk systems MEDIUM TERM: Remediation High Risk systems LONG TERM: Remediation Medium and Low Risk systems TIME FRAME 25 25

26 Qualification Plan Risk Assessment User Requirements Specifications Design Specifications Functional Specifications Configuration Specifications System Build User Acceptance Tests Integration Tests Module Tests System Tests Configuration Tests Qualification Report Traceability Matrix HOW TO MEET REGULATORY EXPECTATIONS PAST REMEDIATION FUTURE Assess Historical Data in case the current status is observed as deficient Data integrity technical measures SOPs & CSV to ensure system reliability Planning Reporting SPECIFICATIONS TESTING ONGOING Requirements and Specifications Definition Testing 0 t0 t Reliable Data 26

27 CONCLUSIONS

28 NOT (ONLY) A TECHNOLOGY MATTER Technologies change our way of working, but the need of Quality Requirements (GxP) remains the same In both the cases Data Integrity must be assured 28

29 CORRELATED COMPONENTS All Data Integrity components (and relevant Compliance Requirements) are essential EVERY ASPECT NOT PROPERLY HANDLED MAY RESULT IN FAILURE USER PROFILES ACCESS CONTROL 29

30 WHERE WE ARE HEADED Globalization has driven the need to create common standards which rely upon the Integrity of GxP data The monitoring of GxP compliance applies to the entire R&D, Manufacturing and Distribution chain Creating a Culture of Quality is the best way to ensure Data Integrity Computer Validation purpose shall be targeted not to technology but to ensure Data Integrity The status of compliance related to Data Integrity must be documented in the present, analyzed with respect to the past and maintained in the future 30

31 GLOBAL PROVIDER, LOCAL SOLUTIONS IN YOUR LANGUAGE

CUSTOMER AND SUPPLIER ROLES AND RESPONSIBILITIES FOR 21 CFR 11 COMPLIANCE ASSESSMENT. 21 CFR Part 11 FAQ. (Frequently Asked Questions)

CUSTOMER AND SUPPLIER ROLES AND RESPONSIBILITIES FOR 21 CFR 11 COMPLIANCE ASSESSMENT. 21 CFR Part 11 FAQ. (Frequently Asked Questions) 21 CFR Part 11 FAQ (Frequently Asked Questions) Customer and Supplier Roles and Responsibilities for Assessment of METTLER TOLEDO STARe Software Version 16.00, including: - 21 CFR 11 Compliance software

More information

EU Annex 11 US FDA 211, 820, 11; other guidelines Orlando López 11-MAY-2011

EU Annex 11 US FDA 211, 820, 11; other guidelines Orlando López 11-MAY-2011 Principle. a. This annex applies to all forms of computerised systems used as part of a GMP regulated activities. A computerised system is a set of software and hardware components which together fulfill

More information

Developing a Robust Quality System to Assure Data Integrity

Developing a Robust Quality System to Assure Data Integrity Developing a Robust Quality System to Assure Data Integrity Maryann Gribbin Chief Compliance Officer, Faith & Royale Consultants Co-Chair PDA Data Integrity Task Force Data Integrity Facts or information

More information

COMPUTERISED SYSTEMS

COMPUTERISED SYSTEMS ANNEX 11 COMPUTERISED SYSTEMS PRINCIPLE This annex applies to all forms of computerised systems used as part of a GMP regulated activities. A computerised system is a set of software and hardware components

More information

GxP Auditing, Remediation, and Quality System Resourcing

GxP Auditing, Remediation, and Quality System Resourcing GxP Auditing, Remediation, and Quality System Resourcing TABLE OF CONTENTS 3 Introduction 4 GxP Auditing 4 GMP Auditing 5 GCP Auditing 6 GLP Auditing 7 Pharmacovigilance Auditing 7 Vendor/Supplier Auditing

More information

GxP Auditing, Remediation, and Staff Augmentation

GxP Auditing, Remediation, and Staff Augmentation GxP Auditing, Remediation, and Staff Augmentation TABLE OF CONTENTS 3 Introduction 4 GxP Auditing 4 GMP Auditing 5 GCP Auditing 5 GLP Auditing 6 Pharmacovigilance Auditing 6 Vendor/Supplier Auditing 7

More information

References Concept. Principle. EU Annex 11 US FDA , (g), (i), 11 Orlando Lopez 2/15/11. Old Annex 11.

References Concept. Principle. EU Annex 11 US FDA , (g), (i), 11 Orlando Lopez 2/15/11. Old Annex 11. References Concept Principle a. This annex applies to all forms of computerised systems used as part of a GMP regulated activities. A computerised system is a set of software and hardware components which

More information

GxP Auditing, Remediation, and Staff Augmentation

GxP Auditing, Remediation, and Staff Augmentation GxP Auditing, Remediation, and Staff Augmentation TABLE OF CONTENTS 3 Introduction 4 GxP Auditing 4 GMP Auditing 5 GCP Auditing 6 GLP Auditing 7 Pharmacovigilance Auditing 7 Vendor/Supplier Auditing 8

More information

EUROPEAN COMMISSION ENTERPRISE AND INDUSTRY DIRECTORATE-GENERAL. EudraLex The Rules Governing Medicinal Products in the European Union

EUROPEAN COMMISSION ENTERPRISE AND INDUSTRY DIRECTORATE-GENERAL. EudraLex The Rules Governing Medicinal Products in the European Union EUROPEAN COMMISSION ENTERPRISE AND INDUSTRY DIRECTORATE-GENERAL Consumer goods Pharmaceuticals Brussels, 08 April 2008 EudraLex The Rules Governing Medicinal Products in the European Union Volume 4 EU

More information

Regulatory Overview Annex 11 and Part 11. Sion Wyn Conformity +[44] (0)

Regulatory Overview Annex 11 and Part 11. Sion Wyn Conformity +[44] (0) Regulatory Overview Annex 11 and Part 11 Sion Wyn Conformity +[44] (0) 1492 642622 sion.wyn@conform-it.com 1 Two Key Regulations Annex 11 21 CFR Part 11 Apply to the regulated company, but often have a

More information

Global Compliance Trends and Warning Letters

Global Compliance Trends and Warning Letters Contact: Charles Lu Director, Quality Carlsbad Tech Phone: (760) 431-8284 Fax: (203) 555-0101 5928 Farnsworth Ct Carlsbad, CA, 92008 www.carlsbadtech.com Global Compliance Trends and Warning Letters Governance

More information

Understanding GxP Regulations for Healthcare

Understanding GxP Regulations for Healthcare Understanding GxP Regulations for Healthcare GxP Guidelines What is GxP? GxP is a collection of quality guidelines and regulations created to ensure that bio/pharmaceutical products are safe, meet their

More information

EU GMP - Annex 11 Computerised systems Versione corrente Nuova versione per commenti (emessa 8 aprile 2008)

EU GMP - Annex 11 Computerised systems Versione corrente Nuova versione per commenti (emessa 8 aprile 2008) EU GMP - Annex 11 Computerised systems Versione corrente Nuova versione per commenti (emessa 8 aprile 2008) Principle The introduction of computerised systems into systems of manufacturing, including storage,

More information

LEVERAGING YOUR VENDORS TO SUPPORT DATA INTEGRITY:

LEVERAGING YOUR VENDORS TO SUPPORT DATA INTEGRITY: LEVERAGING YOUR VENDORS TO SUPPORT DATA INTEGRITY: QUESTIONS TO ASK AND RESPONSIBILITIES TO DOCUMENT Heather Longden Boston Chapter Educational Meeting April 2018 About Waters Lab Informatics Separations

More information

Strategies for Risk Based Validation of Laboratory Systems

Strategies for Risk Based Validation of Laboratory Systems Strategies for Risk Based Validation of Laboratory Systems Video Web Seminar September 23, 2004 Ludwig Huber E-mail: ludwig_huber@agilent.com Today s Agenda Background information: why risk assessment,

More information

GCP Basics - refresher

GCP Basics - refresher p. 01 GCP Basics - refresher Agenda: p. 02 Brief History of GCP GCP Regulations Principles of ICH E6 Sponsor Responsibilities Computer Systems Common Compliance Issues Brief History of GCP 3 Brief History

More information

SIMATIC IT. SIMATIC IT R&D SUITE V7.1 Compliance Response ERES. Introduction 1. The Requirements in Short 2

SIMATIC IT. SIMATIC IT R&D SUITE V7.1 Compliance Response ERES. Introduction 1. The Requirements in Short 2 Introduction 1 The Requirements in Short 2 SIMATIC IT Meeting the Requirements with SIMATIC IT R&D Suite V7.1 3 SIMATIC IT R&D SUITE V7.1 Evaluation List for SIMATIC IT R&D Suite V7.1 4 Product Information

More information

Data Reliability - Internet

Data Reliability - Internet Data Reliability - Internet Wikipedia https://en.wikipedia.org/wiki/reliability_of_wikipedia Others http://www.dailymail.co.uk/health/article- 2639910/Do-NOT-try-diagnose-Wikipedia-90-medicalentries-inaccurate-say-expertsDo.html

More information

Introduction to 21 CFR 11 - Good Electronic Records Management

Introduction to 21 CFR 11 - Good Electronic Records Management INTERNATIONAL JOURNAL OF ADVANCES IN PHARMACY, BIOLOGY AND CHEMISTRY Review Article Introduction to 21 CFR 11 - Good Electronic Records Management Pal Tapas Kumar* and Maity Subhasis NSHM Knowledge Campus,

More information

Impacto de las Nuevas Tendencias Regulatorias en la Producción de Parenterales. Innovacion en Packaging Primario

Impacto de las Nuevas Tendencias Regulatorias en la Producción de Parenterales. Innovacion en Packaging Primario Impacto de las Nuevas Tendencias Regulatorias en la Producción de Parenterales Innovacion en Packaging Primario 1 Contents Company Highlight What s Changing in Pharma Pharma Trends Harmonisation New Requirements

More information

Quality Agreements with CMO s. Presented at ASQ Orange Empire Meeting May 13, 2014 By Luke Foo Sr. Director QA/QC Spectrum Pharmaceuticals

Quality Agreements with CMO s. Presented at ASQ Orange Empire Meeting May 13, 2014 By Luke Foo Sr. Director QA/QC Spectrum Pharmaceuticals Quality Agreements with CMO s Presented at ASQ Orange Empire Meeting May 13, 2014 By Luke Foo Sr. Director QA/QC Spectrum Pharmaceuticals FDA Guidance Contract Manufacturing Arrangements for Drugs: Quality

More information

CSV Inspection Readiness through Effective Document Control. Eileen Cortes April 27, 2017

CSV Inspection Readiness through Effective Document Control. Eileen Cortes April 27, 2017 CSV Inspection Readiness through Effective Document Control Eileen Cortes April 27, 2017 Agenda Background CSV Readiness CSV and Change Management Process Inspection Readiness Do s and Don ts Inspection

More information

Computerised Systems. Alfred Hunt Inspector. Wholesale Distribution Information Day, 28 th September Date Insert on Master Slide.

Computerised Systems. Alfred Hunt Inspector. Wholesale Distribution Information Day, 28 th September Date Insert on Master Slide. Computerised Systems Wholesale Distribution Information Day, Alfred Hunt Inspector Date Insert on Master Slide Slide 1 Index What is a computerised system Updates to EU GDPs Expectations Case studies Slide

More information

Ensure Data Integrity Compliance in the Analytical Laboratory A Life Cycle Approach

Ensure Data Integrity Compliance in the Analytical Laboratory A Life Cycle Approach Ensure Data Integrity Compliance in the Analytical Laboratory A Life Cycle Approach Paresh Patel Director, Scientific Operations Johnson& Johnson QS&S 12/14/2016 1 1 Topics GMP regulatory requirements

More information

Cross-walk between EU Annex 11 and US FDA 211, 820, 11; other guidelines and regulations Orlando López Rev11AUG16

Cross-walk between EU Annex 11 and US FDA 211, 820, 11; other guidelines and regulations Orlando López Rev11AUG16 Principle. a. This annex applies to all forms of computerised systems used as part of a GMP regulated activities. A computerised system is a set of software and hardware components which together fulfill

More information

Implementing Compliant Medical Device Best Practice Business Processes Using Oracle E-Business Suite

Implementing Compliant Medical Device Best Practice Business Processes Using Oracle E-Business Suite Implementing Compliant Medical Device Best Practice Business Processes Using Oracle E-Business Suite A white paper discussing the compliant use of the Oracle Electronic Record, Electronic Signature (E-Records)

More information

Q&A on ICH Q7 Good Manufacturing Practice Questions and Answers Document

Q&A on ICH Q7 Good Manufacturing Practice Questions and Answers Document Q&A on ICH Q7 Good Manufacturing Practice Questions and Answers Document March 2017 International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use 1 ICH Q7 - Questions

More information

Standard operating procedures revisited: a 2014 perspective

Standard operating procedures revisited: a 2014 perspective Pharmaceutical Pharm. Bioprocess. (2014) 2(1), 41 47 Standard operating procedures revisited: a 2014 perspective Approximately 50 years after the good manufacturing practice (GMP) regulations were first

More information

IT Compliance in the FDA Regulated Industry. IT Responsibilities 10 Years Ago TODAY! 11/17/2008. Business. Security. Compliance. IT & Automation Forum

IT Compliance in the FDA Regulated Industry. IT Responsibilities 10 Years Ago TODAY! 11/17/2008. Business. Security. Compliance. IT & Automation Forum IT Compliance in the FDA Regulated Industry IT & Automation Forum November 13, 2007 Caribe Hilton, San Juan Puerto Rico Speaker: Mr. Juan O. Pérez, Principal Consultant joperez@fdcpr.com IT Responsibilities

More information

GLP Computerized Systems Updates from OECD Guidance. Dr. Michael Regehr, BASF Corporation 28 JAN 2016, NAICC, Orlando

GLP Computerized Systems Updates from OECD Guidance. Dr. Michael Regehr, BASF Corporation 28 JAN 2016, NAICC, Orlando GLP Computerized Systems Updates from OECD Guidance Dr. Michael Regehr, BASF Corporation 28 JAN 2016, NAICC, Orlando 1 Validation EPA GLP Obligation Expectations of the EPA for Computers in GLP (40 CFR

More information

Computerised System Validation

Computerised System Validation Computerised System Validation Considerations for the Validation Lifecycle Paul Moody GMP Conference 12 th November 2014 Regulatory References EU GMP Annex 11 (2011) http://ec.europa.eu/health/files/eudralex/vol-4/annex11_01-2011_en.pdf

More information

Audits and Inspections

Audits and Inspections Audits and Inspections Dr. Dirk Feldmann 06. November 2017 First we take measurements, then we take measures. TECHNICAL Content Audits and inspections Types of audits EHS Challenges and chances Preparation

More information

OECD Working Group on Good Laboratory Practice. Template for submission of comments on draft GLP Guidance Documents. Instructions for Use

OECD Working Group on Good Laboratory Practice. Template for submission of comments on draft GLP Guidance Documents. Instructions for Use OECD Working Group on Good Laboratory Practice Template for submission of comments on draft GLP Guidance Documents Instructions for Use 1. First, please complete the table below giving the full name of

More information

White paper: Code of GMP Chapter 4 Documentation - PIC/S versus EU

White paper: Code of GMP Chapter 4 Documentation - PIC/S versus EU White paper: Code of GMP Chapter 4 Documentation - PIC/S versus EU Numerous articles are available comparing the current and previous EU Code of GMP Chapter 4: Documentation, but no comparison exists between

More information

REXS. Risk Expert System

REXS. Risk Expert System REXS Risk Expert System REXS by experts for experts REXS is based on the extensive experience of VTU experts in the GMP and safety sector. The system is specifically designed to support experts engaged

More information

Information Governance for Data Integrity

Information Governance for Data Integrity Information Governance for Data Integrity Presented by: Kip Wolf of Tunnell Consulting Information Systems Track, Session #: SES305 Tuesday 31 OCT 2017 11:40 12:05 Discussion Topics Recent trends in FDA

More information

10 "Must-Haves" for the Life Sciences Learning Management System

10 Must-Haves for the Life Sciences Learning Management System 10 "Must-Haves" for the Life Sciences Learning Management System Why the Life Sciences LMS Needs to Demonstrate Record Control UL talks to many Life Sciences companies that are exploring learning and development

More information

GMP In-house Training

GMP In-house Training Your benefits: Customised to fit your company s requirements - cost-effective and flexible! GMP In-house Training for the Pharmaceutical, API and Medical Device Industry We offer practice-oriented GMP

More information

By Dr. Michael Hiob, Max Lazar, Dr. Christian Gausepohl and Dr. Christine Oechslein. Preparing for the EU GMP Inspection

By Dr. Michael Hiob, Max Lazar, Dr. Christian Gausepohl and Dr. Christine Oechslein. Preparing for the EU GMP Inspection By Dr. Michael Hiob, Max Lazar, Dr. Christian Gausepohl and Dr. Christine Oechslein Preparing for the EU GMP Inspection ISBN: 978-3-943267-79-2 A Process Approach to Pharmaceutical Quality Systems A Guide

More information

THE COMPLETE GUIDE TO ISO14001

THE COMPLETE GUIDE TO ISO14001 THE COMPLETE GUIDE TO ISO14001 1. Introduction... 3 Plan Do Check Act... 5 2. Requirements... 7 Environmental Policy... 7 Environmental Aspects... 7 Legal and Other Requirements... 8 Objectives & Targets...

More information

Vince Anicetti EVP Quality and Compliance, Coherus Biosciences West Coast PDA 20 October 2016

Vince Anicetti EVP Quality and Compliance, Coherus Biosciences West Coast PDA 20 October 2016 Quality Management in a Virtual Environment Vince Anicetti EVP Quality and Compliance, Coherus Biosciences West Coast PDA 20 October 2016 Biosimilars - the second wave of biotech -an evolving regulatory

More information

PAT & Risk-Based Initiatives: Implementation Issues PDA New England - 8 th Dec Cliff Campbell B.E., C.Eng. CC&A Ltd., Cork, Ireland

PAT & Risk-Based Initiatives: Implementation Issues PDA New England - 8 th Dec Cliff Campbell B.E., C.Eng. CC&A Ltd., Cork, Ireland PAT & Risk-Based Initiatives: Implementation Issues PDA New England - 8 th Dec 2004 Cliff Campbell B.E., C.Eng. CC&A Ltd., Cork, Ireland cca@iol.ie 1 FDA Context 1) FDA 5-Part Strategic Plan Protect &

More information

21 CFR Ch. I ( Edition) Personnel Design controls Identification Traceability.

21 CFR Ch. I ( Edition) Personnel Design controls Identification Traceability. Pt. 820 device together with an explanation of the basis for the estimate; (iv) Information describing the applicant s clinical experience with the device since the HDE was initially approved. This information

More information

Compliance Response Electronic Records / Electronic Signatures (ERES) for SIMATIC PCS 7 V8.1

Compliance Response Electronic Records / Electronic Signatures (ERES) for SIMATIC PCS 7 V8.1 Compliance Response Electronic Records / Electronic Signatures (ERES) for SIMATIC PCS 7 V8.1 SIEMENS AG Industry Sector VSS Pharma D-76187 Karlsruhe, Germany E-Mail: pharma@siemens.com March 2015 A5E35829023-AA

More information

Data Integrity: A Structural Approach for Sustainable Outcomes

Data Integrity: A Structural Approach for Sustainable Outcomes Data Integrity: A Structural Approach for Sustainable Outcomes John C. (Jack) Garvey, Esq. Founder / Chief Executive Officer Compliance Architects LLC 2017 Pharmaceutical Quality Congress Speaker Introduction

More information

The interface between Good Clinical Practice and Good Manufacturing Practice

The interface between Good Clinical Practice and Good Manufacturing Practice 1 The interface between Good Clinical Practice and Good Manufacturing Practice your partner in compliance 1 The interface between GCP and GMP Generally, studies are designed and planned by physicians who

More information

Data Integrity in Clinical Trials the Sponsor Perspective

Data Integrity in Clinical Trials the Sponsor Perspective Data Integrity in Clinical Trials the Sponsor Perspective Maximilian Stroebe, GSK Vaccines Three differences to Commercial Manufacturing Long process chains Source Data, Clinical Sites and Outsourcing

More information

Design Qualification SOP

Design Qualification SOP 1.0 Commercial in Confidence 16-Aug-2006 1 of 13 Design Qualification SOP Document No: SOP_0400 Prepared by: David Brown Date: 16-Aug-2006 Version: 1.0 1.0 Commercial in Confidence 16-Aug-2006 2 of 13

More information

ISO 22000:2005 Standard INTERNATIONAL STANDARDS REGISTRATIONS

ISO 22000:2005 Standard INTERNATIONAL STANDARDS REGISTRATIONS ISO 22000:2005 Standard Food Safety Management System INTERNATIONAL STANDARDS REGISTRATIONS 3.1 FOOD SAFETY concept that food will not cause harm to the consumer when it is prepared and/or eaten according

More information

Agenda. 16:00 16:10 Velkommen 16:10 16:15 Inspektion, hvad er det?

Agenda. 16:00 16:10 Velkommen 16:10 16:15 Inspektion, hvad er det? Agenda 16:00 16:10 Velkommen 16:10 16:15 Inspektion, hvad er det? 16:15 17:15 Electronic systems for handling of: Source data Data collection tools 17:15 17:45 Pause og networking 17:45 18:30 Trial Master

More information

WHO Prequalification Team (WHO-PQT) Introduction to medicines inspections technical updates

WHO Prequalification Team (WHO-PQT) Introduction to medicines inspections technical updates Joint UNICEF, UNFPA & WHO meeting with manufacturers and suppliers of diagnostic products, vaccines, finished pharmaceutical products and active pharmaceutical ingredients WHO Prequalification Team (WHO-PQT)

More information

INS QA Programme Requirements

INS QA Programme Requirements Specification Date: 20/3/17 INS QA Programme Requirements UNCONTROLLED WHEN PRINTED Author: J Cooch AUTHORISATION Date: 20/3/17 A Brown Owner: J Cooch (Signature) N.B. only required for hard copy If issued

More information

ISPE GAMP, leading the way to Productive Compliance

ISPE GAMP, leading the way to Productive Compliance ISPE GAMP, leading the way to Productive Compliance AUTHOR: Chris Reid, Chair ISPE GAMP Europe As well as presenting ISPE GAMP principles and practices for effective regulatory compliance, this White Paper

More information

KINGSMANN CARE GROUP

KINGSMANN CARE GROUP PHARMA CONSULTANTS KINGSMANN CARE GROUP KINGSMANN CONSULTANCY SERVICES Thank you for taking interest in Kingsmann Consultancy Services. Kingsmann Consultancy (KC) is a leading business development-consulting

More information

QP s experience with QRM. Fergus O Connell QA Manager AMS Laboratories

QP s experience with QRM. Fergus O Connell QA Manager AMS Laboratories QP s experience with QRM Fergus O Connell QA Manager AMS Laboratories December 2011 Risk Management in a QPs role Validation Master Plan Risk Review Early issues Human Error Risk Influencing Factors EU

More information

GMP On Site Series. GMP Essentials

GMP On Site Series. GMP Essentials GMP On Site Series GMP Essentials GMP Basics Objectives 1. State the critical definitions of the pharmaceutical industry. 2. Describe the law as it applies to various critical functions. 3. State the history

More information

EU and FDA GMP Regulations: Overview and Comparison

EU and FDA GMP Regulations: Overview and Comparison THE QUALITY ASSURANCE JOURNAL, VOL. 2, 55 60 (1997) EU and FDA GMP Regulations: Overview and Comparison The increasing emphasis on global supply of drug products, as well as starting materials and investigational

More information

Quality Agreements and Managing Contract Supplier Quality

Quality Agreements and Managing Contract Supplier Quality Quality Agreements and Managing Contract Supplier Quality American Society for Quality Lloyd Bailey November 3, 2005 Service Mark of The Dow Chemical Company TM Trademark of The Dow Chemical Company Abstract

More information

ENVIRONMENTAL LABORATORY APPROVAL PROGRAM CERTIFICATION MANUAL DATE 5/06/08

ENVIRONMENTAL LABORATORY APPROVAL PROGRAM CERTIFICATION MANUAL DATE 5/06/08 1 of 69 Preface The New York State Department of Health, Wadsworth Center, Environmental Laboratory Approval Program (ELAP) has adopted as its Standard the current version of the National Environmental

More information

QUALITY MANAGEMENT SYSTEM POLICIES AND PROCEDURES

QUALITY MANAGEMENT SYSTEM POLICIES AND PROCEDURES Your Company Name QUALITY MANAGEMENT SYSTEM POLICIES AND PROCEDURES Origination Date: XXXX Document Identifier: Date: Document Revision: QMS-00 QMS Policies and Procedures Latest Revision Date Abstract:

More information

The Impact of Quality Culture on Quality Risk Management. FDA Perspective on Quality Culture; how it Impacts Risk Management

The Impact of Quality Culture on Quality Risk Management. FDA Perspective on Quality Culture; how it Impacts Risk Management The Impact of Quality Culture on Quality Risk Management FDA Perspective on Quality Culture; how it Impacts Risk Management Teresa Gorecki Practice Lead Compliance Architects Agenda The WHAT Definitions

More information

Jean Guichard. Introduction to Good Process Record Management (GxP) #: Internet-WP Version: e1.00 /EN

Jean Guichard. Introduction to Good Process Record Management (GxP) #: Internet-WP Version: e1.00 /EN Jean Guichard White Paper Introduction to Good Process Record Management (GxP) #: Internet-WP Version: e1.00 /EN Introduction to Good Process Record Management (GxP) 2 / 6 Document History Version Date

More information

PART 820 QUALITY SYSTEM REGULATION. 21 CFR Ch. I ( Edition)

PART 820 QUALITY SYSTEM REGULATION. 21 CFR Ch. I ( Edition) 814.126 (b) Withdrawal of IRB approval. A holder of an approved HDE shall notify FDA of any withdrawal of approval for the use of a HUD by a reviewing IRB within 5 working days after being notified of

More information

Compliance Response Electronic Records / Electronic Signatures for COMOS V10.0

Compliance Response Electronic Records / Electronic Signatures for COMOS V10.0 Compliance Response Electronic Records / Electronic Signatures for COMOS V10.0 SIEMENS AG Industry Sector I IA VSS Pharma D-76187 Karlsruhe, Germany E-mail: pharma@siemens.com November 2013 SIEMENS AG

More information

Guidance for Industry - Computerized Systems Used in Clinical Trials

Guidance for Industry - Computerized Systems Used in Clinical Trials Page 1 of 14 Regulatory Information Computerized Systems Used in Clinical Trials Guidance for Industry - Computerized Systems Used in Clinical Trials

More information

The European Medicines Agency Inspections ANNEX IV TO PROCEDURE FOR CONDUCTING GCP INSPECTIONS REQUESTED BY THE EMEA:

The European Medicines Agency Inspections ANNEX IV TO PROCEDURE FOR CONDUCTING GCP INSPECTIONS REQUESTED BY THE EMEA: The European Medicines Agency Inspections London, 20 September 2007 EMEA/INS/GCP/197221/2005 Procedure no.: INS/GCP/3/IV ANNEX IV TO PROCEDURE FOR CONDUCTING GCP INSPECTIONS REQUESTED BY THE EMEA: SPONSOR

More information

Quality Assurance Policy and Procedures

Quality Assurance Policy and Procedures 650 Montana Ave, Suite A Las Cruces, NM 88001 (575) 522-0430 www.rmgovernmentservices.com Quality Assurance Policy and Procedures PURPOSE. The purpose of this policy is to outline the quality assurance

More information

Compliance Program Effectiveness Guide

Compliance Program Effectiveness Guide Compliance Program Effectiveness Guide June 2017 This Guide is a comparison of: Compliance Program Elements New York State, Social Services Law 363-D Office of Inspector General (OIG) Compliance Program

More information

Quality Systems. Indian Pharmaceutical Alliance. Advanced GMP Workshops 2017

Quality Systems. Indian Pharmaceutical Alliance. Advanced GMP Workshops 2017 Quality Systems Indian Pharmaceutical Alliance Advanced GMP Workshops 2017 Presented by Patrick Costello on November 2017 Principal Scientific Administrator Manufacturing & Quality Compliance An agency

More information

GMPs: Distribution Centers

GMPs: Distribution Centers SkillsPlus International Inc. The On-Site Series GMPs: Distribution Centers Learn to apply the GMP regulations as they relate to distribution center operations! FDA Past, Present, and Future and opener

More information

PROPOSAL FOR REVISION OF THE SUPPLEMENTARY GUIDELINES ON GOOD MANUFACTURING PRACTICES: VALIDATION, APPENDIX 7:NON-STERILE PROCESS VALIDATION

PROPOSAL FOR REVISION OF THE SUPPLEMENTARY GUIDELINES ON GOOD MANUFACTURING PRACTICES: VALIDATION, APPENDIX 7:NON-STERILE PROCESS VALIDATION 1 Working document QAS/13.527/Rev.2 August 2014 RESTRICTED 2 3 4 5 6 7 8 9 10 PROPOSAL FOR REVISION OF THE SUPPLEMENTARY GUIDELINES ON GOOD MANUFACTURING PRACTICES: VALIDATION, APPENDIX 7:NON-STERILE PROCESS

More information

COMPUTER SYSTEMS VALIDATION

COMPUTER SYSTEMS VALIDATION COMPUTER SYSTEMS VALIDATION DOCUMENT NO.: POL007 v1.0 AUTHOR: Lorn Mackenzie ISSUE DATE: 04 AUG 2017 1 INTRODUCTION 1.1 The Academic & Clinical Central Office for Research & Development (ACCORD) is a joint

More information

ASQ FD&C GMP Quality Conference

ASQ FD&C GMP Quality Conference ASQ FD&C GMP Quality Conference End User Testing for Performance Qualification of GXP/ Part 11 Systems Off The Shelf (OTS) Dr. Teri Stokes, GXP International, Concord, MA USA www. GXPInternational.com

More information

2015 PDA/FDA Joint Regulatory Conference September 28-30, 2015 Renaissance Washington, DC Downtown Hotel Washington, DC

2015 PDA/FDA Joint Regulatory Conference September 28-30, 2015 Renaissance Washington, DC Downtown Hotel Washington, DC P3: Integrity By: Monica Cahilly Integrity Training Lessons Learned & Case Studies Monica J. Cahilly, M.S. Green Mountain Quality Assurance LLC www.greenmountainqa.com OUTLINE What is Integrity? Good Documentation

More information

Software Quality Regulatory Trends

Software Quality Regulatory Trends Software Quality Regulatory Trends By Praxis Life Sciences 1925 West Field Court, Suite 125, Lake Forest, IL 60045 praxislifesciences.com +1(847) 295-7160 validationcenter.com Software Quality Regulatory

More information

Food and Drug Administration, HHS Pt Sec Scope Definitions Quality system.

Food and Drug Administration, HHS Pt Sec Scope Definitions Quality system. Food and Drug Administration, HHS Pt. 820 authorized designee. If, however, a physician in an emergency situation determines that approval from an IRB cannot be obtained in time to prevent serious harm

More information

Chapter 2 GALP Implementation Assistance

Chapter 2 GALP Implementation Assistance Chapter 2 GALP The GALP Implementation is based on established data management principles. 1. PRINCIPLES Control is the essential objective behind most data management principles. Effective management

More information

ZOLL Document Number: 90E0021 Page 6 of 50 QUALITY SYSTEM MANUAL ZOLL Document Number: 90E0021 Page 7 of 50 1 EXECUTIVE MANAGEMENT APPROVAL... 10 2 INTRODUCTION... 11 3 QUALITY SYSTEM... 12 3.1 QUALITY

More information

The long anticipated draft of the FDA s

The long anticipated draft of the FDA s This article provides an overview of the draft guidance, the key changes in relation to the 1987 guidance, and reviews its potential impact on the current industry approaches to science- and risk-based

More information

How Pharma Should Monitor itself for GMP Compliance & How FDA Inspections Could Incorporate Pharmaceutical Inspection Cooperation Scheme (PIC/S)

How Pharma Should Monitor itself for GMP Compliance & How FDA Inspections Could Incorporate Pharmaceutical Inspection Cooperation Scheme (PIC/S) How Pharma Should Monitor itself for GMP Compliance & How FDA Inspections Could Incorporate Pharmaceutical Inspection Cooperation Scheme (PIC/S) ASQ Northeast Pharmaceutical GMP/Quality Conference January

More information

Reduce paper-based errors

Reduce paper-based errors December 2008 Page 1 Reduce paper-based errors The Syncade Application eliminates the need for paper-based documentation. It enables quick, easy access to electronic information - when it is needed, where

More information

Q10 PHARMACEUTICAL QUALITY SYSTEM

Q10 PHARMACEUTICAL QUALITY SYSTEM Q10 PHARMACEUTICAL QUALITY SYSTEM This draft guidance, when finalized, will represent the Food and Drug Administration's (FDA's) current thinking on this topic. It does not create or confer any rights

More information

PTC s Windchill Product Lifecycle Management (PLM) System Facilitates Part 11 / Annex 11 Compliance

PTC s Windchill Product Lifecycle Management (PLM) System Facilitates Part 11 / Annex 11 Compliance PTC s Product Lifecycle Management (PLM) ystem Facilitates Part 11 / Annex 11 Compliance A White Paper by: Diane Gleinser, r. VP olutions and ervices, UDM Life ciences Michael Prudhomme, olution Director,

More information

Quality Manual. Index

Quality Manual. Index This quality policy manual is for the use of, its Clients, Vendors, and the appropriate Regulatory Agencies. Unauthorized duplication or transfer to others is prohibited. Index Authorization... 3 Introduction...

More information

Seamless Integration of ASTM E2500, Annex 15, FDA Process Validation Guideline and Chinese GMP in Large CapEx Project in China Daniel Nilsson

Seamless Integration of ASTM E2500, Annex 15, FDA Process Validation Guideline and Chinese GMP in Large CapEx Project in China Daniel Nilsson Seamless Integration of ASTM E2500, Annex 15, FDA Process Validation Guideline and Chinese GMP in Large CapEx Project in China Daniel Nilsson Senior Management Consultant Agenda Introduction A state-of

More information

AAMI Quality Systems White Paper: Comparison of 21 CFR Part 820 to ISO 13485:2016 1

AAMI Quality Systems White Paper: Comparison of 21 CFR Part 820 to ISO 13485:2016 1 AAMI s White Paper Comparison of 21 CFR Part 820 to ISO 13485:2016 February 2017 AUTHORS Seb Clerkin, GMP Advisory Services Nicola Martin, Owner, Nicola Martin Consulting Jack Ward, Owner, Ward Sciences

More information

Guidelines for Process Validation of Pharmaceutical Dosage Forms

Guidelines for Process Validation of Pharmaceutical Dosage Forms Guidelines for Process Validation of Pharmaceutical Dosage Forms Version 2.1 Date issued 21/02/2010 Date of implementation 21/05/2010 31 August 2010 Page 1 of 20 Guidelines for Process Validation of Pharmaceutical

More information

Sarbanes-Oxley Compliance Kit

Sarbanes-Oxley Compliance Kit Kit February 2018 This product is NOT FOR RESALE or REDISTRIBUTION in any physical or electronic format. The purchaser of this template has acquired the rights to use it for a SINGLE Disaster Recovery

More information

Medical Device Purchasing Controls Challenges of Compliance in a World Market June, 2013 OMTEC

Medical Device Purchasing Controls Challenges of Compliance in a World Market June, 2013 OMTEC Medical Device Purchasing Controls Challenges of Compliance in a World Market June, 2013 OMTEC - 2013 Quality Business Acceptance Activities 1 ..FDA Across the Globe.. 2 ..Warning Letters and FDA 483 update..

More information

Regulations and guidance for the pharmaceutical industry

Regulations and guidance for the pharmaceutical industry w w w. spec troscopyonline. com April 2011 Spectroscopy 26(4) 1 Focus on Quality Is GMP Annex 11 Europe s Answer to 21 CFR 11? January 2011 saw the publication of the new revision of European Union (EU)

More information

ISO Monitoring and Measurement Nonconformance and Corrective and Preventative Action

ISO Monitoring and Measurement Nonconformance and Corrective and Preventative Action ISO 14001 4.5.1 Monitoring and Measurement 4.5.2 Nonconformance and Corrective and Preventative Action 4.5.1 Monitoring and Measurement The organization shall establish and maintain documented procedures

More information

REPORT 2016/067 INTERNAL AUDIT DIVISION. Audit of management of national staff recruitment in the United Nations Assistance Mission for Iraq

REPORT 2016/067 INTERNAL AUDIT DIVISION. Audit of management of national staff recruitment in the United Nations Assistance Mission for Iraq INTERNAL AUDIT DIVISION REPORT 2016/067 Audit of management of national staff recruitment in the United Nations Assistance Mission for Iraq Overall results relating to the effective management of national

More information

Christian Gausepohl, Frank Böttcher. GMP Focus. Managing Contract Manufacturers and Testing Labs. PDF Download. Excerpt from the GMP MANUAL

Christian Gausepohl, Frank Böttcher. GMP Focus. Managing Contract Manufacturers and Testing Labs. PDF Download. Excerpt from the GMP MANUAL Christian Gausepohl, Frank Böttcher GMP Focus Managing Contract Manufacturers and Testing Labs PDF Download Excerpt from the GMP MANUAL Bibliographic Data of the Deutsche Nationalbibliothek: http://dnb.ddb.de

More information

Risk-Based Approach to Software Quality and Validation

Risk-Based Approach to Software Quality and Validation Risk-Based Approach to Software Quality and Validation By Praxis Life Sciences 1925 West Field Court, Suite 125, Lake Forest, IL 60045 praxislifesciences.com +1(847) 295-7160 validationcenter.com Risk

More information

Version 1.0 August 30, 2017

Version 1.0 August 30, 2017 Supplier Requirements Guideline 1.0 Purpose The purpose of this Supplier Requirements Guideline is to provide a guidance document with the expectations and requirements Baxter has of its suppliers. The

More information

Implementation Life-cycle SOP

Implementation Life-cycle SOP 1.0 Commercial in Confidence 11-Aug-2006 1 of 12 Implementation Life-cycle SOP Document No: H4_SOP_0100 Prepared by: David Brown Date: 11-Aug-2006 Version: 1.0 1.0 Commercial in Confidence 11-Aug-2006

More information

Textvergleich. Verglichene Dokumente MEDIA3917.pdf. ICH_Q10_Step4.pdf

Textvergleich. Verglichene Dokumente MEDIA3917.pdf. ICH_Q10_Step4.pdf Textvergleich Verglichene Dokumente MEDIA3917.pdf ICH_Q10_Step4.pdf Übersicht 2270 Wort/Wörter hinzugefügt 1338 Wort/Wörter gelöscht 3558 Wort/Wörter übereinstimmend 157 Block/Blöcke übereinstimmend Blättern

More information

Section 1: Purpose & Objectives of PCI 3000 Certification Program

Section 1: Purpose & Objectives of PCI 3000 Certification Program The Powder Coating Institute PCI 3000 Certification Program Revised 7/7/2014 Any copy, reproduction or unauthorized distribution of this material without written consent from The Powder Coating Institute

More information

Impact of WHO Guidelines on GMP for Blood Establishments

Impact of WHO Guidelines on GMP for Blood Establishments Impact of WHO Guidelines on GMP for Blood Establishments Christian Schärer, Ph.D. Swissmedic, Swiss Agency for Therapeutic Products, Head Inspectorate International Conference of Drug Regulatory Authorities

More information

How to support compliance with GAMP 5

How to support compliance with GAMP 5 PRESENTATION How to support compliance with GAMP 5 KERESZTESI Kálmán Controsys Irányítástechnikai Kft. kalman.keresztesi@controsys.hu Agenda What is GAMP 5 about? Application Lifecycle Management in automation

More information